Evidence map›Paper›PMID 41704561›Full record

ArticleOne health (Amsterdam, Netherlands)2026

Impact of reducing colistin use on colistin resistance in

Soe Yu Naing, Juliëtte Severin, Aldert Zomer, Kuntaman Kuntaman, Imron Suandy, Sunandar Sunandar, Annisa Rachmawati, Nofita Nurbiyanti, Mira Leonie Schneiders, Koen Peeters Grietens and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Soe Yu NaingDivision of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
Juliëtte SeverinDepartment of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Aldert ZomerDivision of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
Kuntaman KuntamanDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Imron SuandyBalai Besar Veteriner Denpasar, Denpasar, Indonesia.
Sunandar SunandarCenter for Indonesian Veterinary Analytical Studies, Bogor, Indonesia.
Annisa RachmawatiCenter for Indonesian Veterinary Analytical Studies, Bogor, Indonesia.
Nofita NurbiyantiCenter for Indonesian Veterinary Analytical Studies, Bogor, Indonesia.
Mira Leonie SchneidersDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Koen Peeters GrietensDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Alicia WidyaDepartment of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Linda van der Graaf-van BlooisDivision of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
Mathieu PruvotFaculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
Diego NobregaFaculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
Anis KaruniawatiDivision of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
Jaap A WagenaarDivision of Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Colistin is a last-resort antimicrobial used to treat infections caused by multidrug-resistant Gram-negative bacteria in humans. In Indonesia, widespread detection of colistin use and resistance in commensal Methods and analysis: COINCIDE will: (i) assess phenotypic and genotypic colistin resistance in Conclusion: By integrating microbiological, epidemiological, policy, and social science data, findings from the COINCIDE study will provide a strong scientific basis to inform AMR policies in Indonesia, with potential significance to inform other countries across Southeast Asia.

Identifiers

PMID41704561
PMCPMC12907006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.